https://www.live-feeds.com/feed/a-new-drug-lifts-the-fog-of-sleepiness-for-those-with-narcolepsyContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/a-new-drug-lifts-the-fog-of-sleepiness-for-those-with-narcolepsyhttps://www.live-feeds.com/feed/a-new-drug-lifts-the-fog-of-sleepiness-for-those-with-narcolepsy#u64606Fri, 11 Sep 2026 03:12:32 +0000The FDA has approved oveporexton, marketed as Orzeyful, a first-in-class orexin agonist designed to treat narcolepsy type 1. Data from Phase 3 studies published in the New England Journal of Medicine show the drug improves quality of life and the full range of symptoms associated with the disorder. Takeda announced the publication of this study data, which supports the drug's ability to reduce the sleepiness fog experienced by patients. The medication has also secured global approvals to provide a new treatment option for those living with the sleep disorder.Why it mattersNarcolepsy type